共 50 条
- [41] YM155 kills quiescent (G0/G1) multiple myeloma and bortezomib resistant cells via inhibition of survivin and Mcl-1 CANCER SCIENCE, 2018, 109 : 1142 - 1142
- [42] Synergistic cytotoxicity of decitabine and YM155 in leukemia cells through upregulation of SLC35F2 and suppression of MCL1 and survivin expression Apoptosis, 2024, 29 : 503 - 520
- [43] YM155 enhances ABT-737-mediated apoptosis through Mcl-1 downregulation in Mcl-1-overexpressed cancer cells Molecular and Cellular Biochemistry, 2017, 429 : 91 - 102
- [44] YM155 Down-Regulates Survivin and Induces P53 Up-Regulated Modulator of Apoptosis ( PUMA)-Dependent in Oral Squamous Cell Carcinoma Cells MEDICAL SCIENCE MONITOR, 2017, 23 : 1963 - 1972
- [46] Survivin Inhibitor YM-155 Sensitizes Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand-Resistant Glioma Cells to Apoptosis through Mcl-1 Downregulation and by Engaging the Mitochondrial Death Pathway JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2013, 346 (02): : 201 - 210
- [48] Phase I safety and pharmacokinetic study of YM155, a potent selective survivin inhibitor, in combination with erlotinib in patients with EGFR TKI refractory advanced non-small cell lung cancer Cancer Chemotherapy and Pharmacology, 2020, 86 : 211 - 219